Objectives: We studied the role of minor mismatch repair proteins (MMR) human MutL homologue 1 (hMLH1) and human MutS homologue 2 (hMSH2) in the main subtypes of renal cell carcinoma (RCC).
Methods: Expression of MMR proteins hMLH1 and hMSH2 were investigated in 166 RCC tumors, containing the main subtypes by immunohistochemistry. Furthermore, each tumor was screened for microsatellite instability (MSI) using the National Cancer Institute consensus panel for hereditary non-polyposis colon carcinoma as well as for elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) by 10 additional markers.
Results: MSI was found only in 2.0% of analyzable cases and EMAST was detected only in 1 patient. hMLH1 and hMSH2 expression was reduced in 83.7 (118/141) and 51.2% (65/127) of cases, respectively, in a subtype-specific manner. None of the clear cell RCC tumors retained a high hMLH1 expression and 92.0% lost hMLH1 completely, while papillary and chromophobe RCC preserved the expression in 25.0 and 33.3% of cases (p < 0.001). Subtype specificity was also present in hMSH2 staining, where chromophobe RCC retained a high expression in 41.7% of cases, while clear cell and papillary tumors did not (29.9 and 23.1%; p = 0.01).
Conclusion: MSI and EMAST are rare events in sporadic RCC, whereas diminished MMR protein expression is linked to tumor entity and might contribute to the different biological behavior of the RCC subtypes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000335642 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
BRAF immunohistochemistry can reliably substitute BRAF molecular testing in the Lynch syndrome screening algorithm in colorectal cancer.
Histopathology
April 2024
IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Aims: The Lynch syndrome (LS) screening algorithm requires BRAF testing as a fundamental step to distinguish sporadic from LS-associated colorectal carcinomas (CRC). BRAF testing by immunohistochemistry (IHC) has shown variable results in the literature. Our aim was to analyse concordance between BRAF IHC and BRAF molecular analysis in a large, mono-institutional CRC whole-slide, case series with laboratory validation.
View Article and Find Full Text PDFDNA Mismatch Repair System Imbalances in Breast Adenocarcinoma.
Cancer Diagn Progn
March 2023
Breast Unit, 1st Department of Obstetrics and Gynaecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.
DNA mismatch repair system (MMR) is considered a leading genetic mechanism in stabilizing DNA structure and maintaining its function. DNA MMR is a highly conserved system in bacteria, prokaryotic, and eukaryotic cells, and provides the highest protection to DNA by repairing micro-structural alterations. DNA MMR proteins are involved in the detection and repair of intra-nucleotide base-to-base errors inside the complementary DNA strand recognizing the recently synthesized strand from the parental template.
View Article and Find Full Text PDFImmune evasion phenotype is common in Richter transformation diffuse large B-cell lymphoma variant.
Virchows Arch
June 2023
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Article Synopsis
- Immune checkpoint inhibitors, specifically PD-1 inhibitors, show potential as a new treatment for patients with Richter transformation-diffuse large B-cell lymphoma variant (RT-DLBCL), based on a study of 64 patients.
- The study categorized tumor expression levels of PD-1, PD-L1, CD30, and microsatellite instability, identifying a subset of patients (43.7%) with an "immune evasion phenotype" (IEP+) that displayed significantly higher levels of PD1-positive tumor-infiltrating lymphocytes (TILs).
- Patients with brisk PD1+ TILs had a notably better overall survival rate compared to those with lower levels of TILs, indicating a correlation between immune response
The Effect of Tobacco Smoke -Nitrosamines, NNK and NDEA, and Nicotine, on DNA Mismatch Repair Mechanism and miRNA Markers, in Hypopharyngeal Squamous Cell Carcinoma: An In Vivo Model and Clinical Evidence.
Curr Oncol
August 2022
The Yale Larynx Laboratory, Department of Surgery, Yale School of Medicine, New Haven, CT 06510, USA.
Deregulation of the DNA mismatch repair (MMR) mechanism has been linked to poor prognosis of upper aerodigestive tract cancers. Our recent in vitro data have provided evidence of crosstalk between deregulated miRNAs and MMR genes, caused by tobacco smoke (TS) -Nitrosamines, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in hypopharyngeal cells. Here, we explored whether chronic exposure to TS components can affect MMR mechanism and miRNA profiles in hypopharyngeal mucosa.
View Article and Find Full Text PDFMismatch repair system in colorectal cancer. Frequency, cancer phenotype, and follow-up.
Rev Gastroenterol Mex (Engl Ed)
November 2022
Departamento de Patología, Instituto Nacional de Ciencias Médicas y Nutrición «Salvador Zubirán», Mexico City, Mexico. Electronic address:
Introduction And Aims: A frequent task in the study of colorectal carcinomas (CRC) is to identify tumors harboring deficient DNA mismatch repair systems (dMMR), which are associated with microsatellite instability. Given that there is scant information on those tumors in Mexican patients, our aim was to describe their frequency, clinical and pathologic characteristics, and results, which are necessary for future trials.
Materials And Methods: A consecutive series of CRC patients, treated and followed at a tertiary care center was performed.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!